Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets - PubMed (original) (raw)

Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets

Brian Boylan et al. Blood. 2008.

Abstract

Immunoreceptor tyrosine-based activation motif (ITAM)-containing proteins have recently been demonstrated in macrophages and neutrophils to be required for cell surface integrins to transmit activation signals into the cell. To identify ITAM-bearing proteins that mediate signaling via the platelet-specific integrin alphaIIbbeta3, fibrinogen binding was induced by (1) allowing platelets to spread directly on immobilized fibrinogen, or (2) activating the PAR1 thrombin receptor on platelets in suspension. Both initiated strong, ligand binding-dependent tyrosine phosphorylation of the ITAM-bearing platelet Fc receptor, FcgammaRIIa, as well as downstream phosphorylation of the protein tyrosine kinase Syk and activation of phospholipase Cgamma2 (PLCgamma2). Addition of Fab fragments of an FcgammaRIIa-specific monoclonal antibody strongly inhibited platelet spreading on immobilized fibrinogen, as well as downstream tyrosine phosphorylation of FcgammaRIIa, Syk, and PLCgamma2, and platelets from a patient whose platelets express reduced levels of FcgammaRIIa exhibited markedly reduced spreading on immobilized fibrinogen. Finally, fibrinogen binding-induced FcgammaRIIa phosphorylation did not occur in human platelets expressing a truncated beta3 cytoplasmic domain. Taken together, these data suggest that ligand binding to platelet alphaIIbbeta3 induces integrin cytoplasmic domain-dependent phosphorylation of FcgammaRIIa, which then enlists selected components of the immunoreceptor signaling cascade to transmit amplification signals into the cell.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Outside-in signaling initiated by platelet interaction with immobilized fibrinogen activates the FcγRIIa signal transduction pathway. (A) Schematic showing use of the FcγRIIa signaling pathway downstream of αIIbβ3 engagement. Note the importance of physical approximation of the integrin with FcγRIIa, allowing integrin-associated Src family members to function as ITAM kinases, thus initiating the outside-in signaling cascade. (B,C) Washed platelets were plated onto 8-chamber glass tissue-culture slides coated with either BSA or fibrinogen (Fg), and allowed to spread for 45 minutes in the presence or absence of 10 μg/mL IV.3 Fab Immunoprecipitation and Western blot analysis (B) reveals strong activation of FcγRIIa, Syk, and PLCγ2 after platelet binding to immobilized fibrinogen, and inhibition of this outside-in signaling pathway by Fab fragments of mAb IV.3. (C) Effect of IV.3 on platelet spreading. Preincubation of platelets with IV.3 Fab markedly inhibits platelet spreading on immobilized fibrinogen, shown in panels A through C, with quantitative analysis of the pixel area of spread platelets in panel. Data shown are the mean plus or minus SEM from one of 4 representative experiments using 3 different platelet donors.

Figure 2

Figure 2

Agonist-induced activation of human platelets results in tyrosine phosphorylation of FcγRIIa, Syk, and PLCγ2 in a ligand binding–dependent manner. Washed human platelets stirring in an aggregometer cuvette were stimulated with TRAP in the presence or absence of 2 mM RGD peptide or 10 μg/mL IV.3 Fab, as indicated. After detergent lysis, proteins were immunoprecipitated using antibodies specific for FcγRIIa, Syk, or PLCγ2, and immunoblots containing immunoprecipitated proteins stained either for antigen (Ag) or phosphotyrosine (PY). Note that FcγRIIa, Syk, and PLCγ2 each become tyrosine phosphorylated after platelet activation, and that preventing ligand binding with RGD peptide (left half of the figure) largely inhibits tyrosine phosphorylation of each of these signaling components, demonstrating that ligand binding to the integrin αIIbβ3 activates the FcγRIIa→Syk→PLCγ2 signaling pathway. Also note that preincubation of platelets with IV.3 (right half of the figure) prevents FcγRIIa, Syk, and PLCγ2 activation in response to TRAP. Data shown are representative of 3 separate experiments performed using 2 different platelet donors.

Figure 3

Figure 3

Human platelets expressing decreased FcγRIIa fail to spread on immobilized fibrinogen. (A-C) Flow cytometric analysis of washed platelets from a patient with an autoantibody specific for GPVI, demonstrating approximately 60% reduced expression of FcγRIIa (as reported by the binding if mAb IV.3), but normal expression of αIIbβ3 and the GPIb complex. (D,E) Washed patient platelets or control platelets from a healthy donor were allowed to spread on glass slides that had been coated with 100 μg/mL fibrinogen. The degree of platelet spreading was analyzed at both 30 and 60 minutes. Note that the patient's platelets failed to spread. Data are the mean plus or minus SEM.

Figure 4

Figure 4

The cytoplasmic domain of the integrin β3 subunit is required for ligand binding–induced phosphorylation of FcγRIIa. Washed platelets from a patient expressing a homozygous mutant form of a Δ724 β3 integrin subunit were plated onto immobilized fibrinogen or BSA and allowed to spread for 45 minutes at 37°C. Note the failure of platelets harboring a truncated β3 cytoplasmic tail to support tyrosine phosphorylation of FcγRIIa (A) or to spread on immobilized fibrinogen (B,C). Representative pictures are shown in panel B, with the average pixel area of 148 to 350 platelets per condition quantitated and shown in panel C. Error bars show mean plus or minus SEM.

Similar articles

Cited by

References

    1. Jackson SP, Nesbitt WS, Kulkarni S. Signaling events underlying thrombus formation. J Thromb Haemost. 2003;1:1602–1612. - PubMed
    1. Abraham RT, Weiss A. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat Rev Immunol. 2004;4:301–308. - PubMed
    1. Humphrey MB, Lanier LL, Nakamura MC. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev. 2005;208:50–65. - PubMed
    1. Monroe J. GITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat Rev Immunol. 2006;6:283–294. - PubMed
    1. Lanier LL, Corliss B, Wu J, Phillips JH. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity. 1998;8:693–701. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources